MSU researchers now can identify more proteins, or biomarkers, in blood plasma, including those linked to specific diseases like cancer. By identifying these biomarkers earlier, medical researchers can create better diagnostic tests and drugs that target diseases sooner, improving patient outcomes.
Tag: Diagnostic Tests
Big gaps seen in home medical test use by older adults
With free COVID-19 rapid tests now shipping to households nationwide, and many other types of at-home medical tests now available, a new study looks at what older adults think about the ability to get answers to medical questions without leaving home.
Study Challenges ED Protocols for Geriatric Head Injuries and Blood Thinners
Out of 3,425 patients enrolled in the study, 0.4% (13 patients) experienced a delayed intracranial hemorrhage, a significantly lower rate than previously reported (7.2%).
Researchers Design Multiclass Cancer Diagnostic Tool Using AI, MicroRNA
MicroRNAs, or miRNAs, regulate genes and biological processes in the human body, including cancer formation and development. To explore the feasibility of miRNAs as cancer biomarkers, researchers created a multiclass cancer diagnostic model using miRNA expression profiles. The study examined the relationship between the composition of miRNAs and various types of cancers. Findings suggest that miRNAs may be highly unique to specific cancerous tissues and can be strong biomarkers for detection and classification in both research and the clinical field
Race of people given Alzheimer’s blood tests may affect interpretation of results
Three of four blood tests used to identify people in early stages of Alzheimer’s disease perform differently in Black individuals compared to white individuals, according to a new study from Washington University School of Medicine in St. Louis. Such differences may put Black patients at risk of misdiagnosis.
Blood test at COVID-19 diagnosis can predict disease severity
In addition to its predictive value, the discovery could lead to new treatments to prevent deadly cytokine storms. It also may help explain why diabetes contributes to worse outcomes in patients with COVID-19.